The demethylating agent decitabine at a low dose was proved to restore the methylation level and expression of PD-1 on CD8+ T cells and reduce the cytotoxicity of CTLs of ITP patients. The gene discussed is CD8A; the disease is autoimmune thrombocytopenic purpura.